ORPHAZYME A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,090 DKK | -0.91% |
|
+4.11% | -18.05% |
| Mar. 27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
Quotes 5-day view
Delayed Quote Nasdaq Copenhagen| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
|---|---|---|---|---|
| Last | 1094.4 kr | 1074.8 kr | 1100 kr | 1090 kr |
| Volume | 63 | 14 | 237 | 30 |
| Change | +8.90% | -1.79% | +2.34% | -0.91% |
| Opening | 991.10 | 951.50 | 1,055.00 | 975.10 |
| High | 1,094.40 | 1,074.80 | 1,100.00 | 1,099.00 |
| Low | 975.00 | 951.50 | 1,055.00 | 975.10 |
Performance
| 1 day | -0.91% | ||
| 1 week | +4.11% | ||
| Current month | -9.15% | ||
| 1 month | -8.39% | ||
| 3 months | -9.29% | ||
| 6 months | +23.86% | ||
| Current year | -18.05% | ||
| 1 year | +13.54% | ||
| 3 years | -98.20% | ||
| 5 years | -98.11% |
Volumes
marketsDaily volume
30
Estimated daily volume
30
Avg. Volume 20 sessions
53
Daily volume ratio
0.57
Avg. Volume 20 sessions DKK
57 770.00
Avg. Volume 20 sessions USD
8 284.51
Record volume 1
16 795
Record volume 2
15 000
Record volume 3
10 208
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (DKK)
5 581 850
Capitalization (USD)
5 581 850
Net sales ()
0
Number of employees
1
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
59.56 %
Free-Float capitalization (DKK)
3 324 735
Free-Float capitalization (USD)
3 324 735
Average Daily Capital Traded
1.03%
Highs and lows
1 week
951.50
1 100.00
1 month
951.101 130.00
Current year
850.001 400.00
1 year
407.005 370.00
3 years
407.00109 100.00
5 years
407.00137 500.00
10 years
407.00137 500.00
Indicators
Moving average 5 days
1 064.24
Moving average 20 days
1 107.77
Moving average 50 days
1 168.95
Moving average 100 days
1 173.35
Price spread / (MMA5)
-2.36%
Price spread / (MMA20)
+1.63%
Price spread / (MMA50)
+7.24%
Price spread / (MMA100)
+7.65%
STIM
RSI 9 days
46.34
RSI 14 days
44.52
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.91% | +4.11% | -18.05% | +13.54% | 5.58M | ||
| -0.06% | +0.81% | -2.31% | +22.94% | 103B | ||
| -0.84% | -1.52% | +0.56% | +13.52% | 95.71B | ||
| +0.90% | +3.56% | +1.69% | +0.60% | 22.02B | ||
| +0.58% | +0.46% | -17.37% | -21.15% | 20.9B | ||
| +2.04% | -2.57% | -9.30% | -29.49% | 17.85B | ||
| +3.17% | +1.71% | -41.01% | -37.19% | 16.21B | ||
| +3.38% | +18.58% | -14.85% | -37.58% | 15.52B | ||
| -1.28% | +3.02% | +3.21% | +32.39% | 13.86B | ||
| +1.08% | +11.37% | +33.54% | +5.31% | 12.04B | ||
| +1.98% | -1.93% | -24.71% | -33.33% | 8.08B | ||
| -0.75% | -3.05% | +7.90% | +77.79% | 7.82B | ||
| +0.95% | +0.62% | +0.17% | +51.30% | 7.64B | ||
| +7.91% | +17.17% | +299.30% | +280.10% | 7.59B | ||
| +0.72% | +5.24% | -1.21% | +28.46% | 6.94B | ||
| +0.83% | -3.27% | -21.74% | +75.93% | 6.79B | ||
| Average | +0.76% | +3.07% | +12.24% | +27.70% | ||
| Weighted average by Cap. | +0.31% | +1.56% | +2.37% | +15.46% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
b1e9c0a7d722807e8e28d084.d05bVRSfDvjlRgNYHFhip3f7zF68EAe4zTW7iUGKdJM.OXg5NECsS4C_dm8XRmso5DOypm7JUUWAq1PW4i28PKVPAishV69_u4wMQg
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 07:28:59 am | 1,090 | 7 | 30 |
| 06:59:13 am | 1,090 | 1 | 23 |
| 06:59:13 am | 1,090 | 3 | 22 |
| 06:59:13 am | 1,090 | 1 | 19 |
| 06:58:37 am | 1,001 | 3 | 18 |
| 06:58:37 am | 1,001 | 1 | 15 |
| 06:52:43 am | 1,090 | 3 | 14 |
| 06:52:43 am | 1,090 | 3 | 11 |
| 06:07:53 am | 1,099 | 3 | 8 |
| 06:07:53 am | 1,095 | 1 | 5 |
Monthly variations
Annual change
| 2024 | -18.05% | ||
| 2023 | +51.14% | ||
| 2022 | -94.87% | ||
| 2021 | -74.43% | ||
| 2020 | -7.32% | ||
| 2019 | +67.01% | ||
| 2018 | -42.96% | ||
| 2017 | -5.00% |
- Stock Market
- Equities
- ORPHA Stock
- Quotes Orphazyme A/S
